MetLife Beats Q3 EPS Estimates But Reports Revenue Shortfall

MetLife Beats Q3 EPS Estimates But Reports Revenue Shortfall

US | Financial Services | Insurance - Life | NYSE

MetLife, Inc. (MET) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:


MetLife Beats Earnings Per Share Estimates in Third Quarter

MetLife Inc. (NYSE: MET) on November 5, 2025, reported third-quarter financial results that surpassed earnings expectations but fell short on revenue. The company announced strong performance in its investment portfolio and growth in core operations.

The global insurance provider posted an earnings per share (EPS) of $2.34, which was higher than the estimated $2.31. Adjusted earnings per share, which exclude certain items, increased by 21% to $2.37. The company's adjusted earnings grew by 15% to $1.6 billion, driven by higher variable investment income and volume growth.

Despite the positive earnings, MetLife's total revenue for the quarter was $17.36 billion, missing the consensus estimate of $18.64 billion. The company reported a net income of $818 million for the period.

Key financial metrics show the company's price-to-earnings (P/E) ratio at approximately 12.31 and a price-to-sales ratio of about 0.72. MetLife's financial position includes a debt-to-equity ratio of approximately 0.72. For further information, see the company's financial health summary and investor profile.

DCF model

MetLife, Inc. (MET) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.